COSA 2015* Val Gebski
National Health Medical Research Council, Clinical Trials Centre, NSW, Australia
Presentations this author is a contributor to:
A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours: The P3BEP Trial (ANZUP 1302) (#266)
3:00 PM
Howard Chan
Posters1
SIRFLOX: Randomised phase III trial comparing first-line mFOLFOX6 ± bevacizumab (bev) versus mFOLFOX6 ± bev + selective internal radiation therapy (SIRT) in patients with metastatic colorectal cancer (mCRC) - analysis by presence or absence of extra-hepatic metastases, bev treatment and site of first progression (#20)
11:30 AM
Peter Gibbs
Best of the Best Orals - Clinical research